Contact | Compliance | Reimbursement | Supply Updates | Supplier Link
Investor Relations

A HERITAGE OF INNOVATION AND LEADERSHIP

Lantheus Medical Imaging, a global leader in developing, manufacturing, selling, and distributing innovative diagnostic imaging agents, is dedicated to creating and providing medical imaging solutions to improve the treatment of human disease.

Our expertise in discovering, developing and commercializing innovative medical imaging agents provides a strong platform from which to bring forward breakthrough tools for the diagnosis and management of disease. Lantheus has a rich heritage and expertise in cardiovascular imaging and nuclear medicine, having pioneered many of the most significant products used in medical imaging.

Our current imaging agents primarily assist in the diagnosis of heart, vascular and other diseases using nuclear imaging, echocardiography and magnetic resonance imaging (MRI) technologies. We have a pipeline of next-generation and first-in-class products using Positron Emission Tomography (PET) and MRI technologies.

Our vision is to be the leading provider of innovative medical imaging solutions to improve human life. We are committed to developing next generation and first-in-class imaging agents to assist physicians in the diagnosis of heart, vascular and other diseases.

With direct operations in the United States, Puerto Rico, Canada and Australia, we have a long and distinguished history of developing and commercializing innovative market-changing products.

Recent News

Lantheus Medical Imaging Reports 2014 Fourth Quarter and Full Year Financial Results

Fourth quarter worldwide revenue increases 7% as-reported and 9% constant currency; strong DEFINITY®  performance driven by continued market adoption and share gains

Fourth quarter Adjusted EBITDA increases 28% to $19.4 million; Company posts full year Adjusted EBITDA of $70.8 million

No. BILLERICA, Mass. (March 4, 2015) – Lantheus Medical Imaging, Inc. (“Lantheus” or “the Company”), a wholly-owned operating subsidiary of parent company Lantheus MI Intermediate, Inc. and a global leader in developing, manufacturing, selling and distributing innovative diagnostic imaging agents, today reported financial results for its fourth quarter and full year ended December 31, 2014.

click here for the press release

Company Spotlight

Webcast Image Webcast
Q4 2014 Lantheus Medical Earnings Conference Call (Live)
Wednesday, March 4, 2015 at  4:30 p.m. ET
© 2014 Lantheus Medical Imaging, Inc. Contact | Compliance | Reimbursement | Supply Updates | Supplier Link | Site Map